Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Although early clinical trials have been positive, peptide vaccine mechanism of action (how tolerance is induced) is unknown. The primary objective of these studies is to identify changes in gene expression and cytokine expression that are correlated with vaccine treatment. These changes could provide insight to mechanisms of action and may reveal potential genetic biomarkers that could then be validated for use in clinical development of peptide vaccines, and also the treatment of allergic disease. If this study can identify the key genes can cellular pathways that respond to treatment with a peptide vaccine to cat allergy, it will represent a great advance in the understanding of the mechanisms of immunotolerance. Such knowledge may then be applied to the design of dosing regimens, clinical trial design, and the development of other peptide based immunotherapeutics.
Dr. Mark Larché
Elena Tonti
Adiga Life Science Inc.
Medicine
Life sciences
McMaster University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.